TCRT: 69% | Alaunos Therapeutics On Thursday Filed Patent Application "Identification Of Neoantigen-Reactive T Cell Receptors"

 

MEDS: 24% | DataMeds AI Settles Litigation Related To Outstanding Debt And Receivables Related To The 2023 Wellgistics Agreement; Company Retired ~364,099 MEDS Shares And Paid $450K In Cash

 

XENE: -26% | Xenon Pharmaceuticals shares are trading lower after the company announced it voluntarily initiated a temporary pause of enrollment of new patients in ongoing psychiatry studies.